Find clinical trials for Eczema in Paris, Île-de-France
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Atopic Dermatitis
Dermatitis
Pruritus
Food Hypersensitivity
Hidradenitis
Hidradenitis Suppurativa
Hypersensitivity
Eczema trials near Paris, Île-de-France, FRA:
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab
Phase 3
Paris, France and 555 other locations
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description
Active, not recruiting
Moderate-to-Severe Atopic Dermatitis
Drug: Nemolizumab
Phase 3
Paris, France and 342 other locations
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems